Get the Stockscreener App
4.7601
1.47%
0.0601
23 Andme Holding Co stock is traded at $4.7601, with a volume of 97,453.
It is up +1.47% in the last 24 hours and down -19.11% over the past month.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
See More
Previous Close:
$4.70
Open:
$4.7
24h Volume:
97,453
Relative Volume:
0.52
Market Cap:
$119.62M
Revenue:
$247.99M
Net Income/Loss:
$-521.97M
P/E Ratio:
-6.6113
EPS:
-0.72
Net Cash Flow:
$-194.28M
1W Performance:
-3.46%
1M Performance:
-19.11%
6M Performance:
-52.53%
1Y Performance:
-74.41%
1-Day Range:
$4.62
$4.80
1-Week Range:
$4.5674
$5.0069
52-Week Range:
$4.5674
$20.40
23 Andme Holding Co Stock (ME) Company Profile
Name
23 Andme Holding Co
Sector
Industry
Phone
(650) 938-6300
Address
349 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-22 | Initiated | Berenberg | Buy |
| Sep-22-22 | Initiated | Cowen | Outperform |
| Nov-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Jul-12-21 | Initiated | Citigroup | Buy |
23 Andme Holding Co Stock (ME) Latest News
Vanguard Group's Strategic Acquisition of 23andMe Shares - GuruFocus.com
23andMe regains Nasdaq compliance, avoids delisting By Investing.com - Investing.com Australia
23andMe regains Nasdaq compliance, avoids delisting - Investing.com
23andMe Regains Nasdaq Compliance and Ensures Listing - TipRanks
23andMe Regains Compliance With Nasdaq Listing Requirements - GlobeNewswire
23andMe Stock Price Prediction: 2024, 2025, 2030 - Benzinga
23andMe Holding Expands Board with New Appointments - TipRanks
23andMe expands board with three new directors - Investing.com
23andMe Appoints Three New Independent Directors to Board - GlobeNewswire
23andMe expands board with three new directors By Investing.com - Investing.com UK
23andMe Holding Co. (ME) Appoints Andre Fernandez, Jim Frankola, and Mark Jensen to its Board - StreetInsider.com
BANKRUPTCY THREAT: How KY & IN 23andMe Clients Can Protect Themselves - WBKR
US Judge OKs $110 Million Settlements in Antitrust Case Against Major Real Estate Brokerages - PYMNTS.com
Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues - Yahoo Finance
23andMe: Liquidity Pressures And Operational Instability Pose Significant Risks - Seeking Alpha
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - MSN
23andMe Holding Co. (NASDAQ:ME) Sees Large Decline in Short Interest - MarketBeat
23andMe Holding Co. (ME) Stock Price, News, Quote & History - Yahoo Finance
23andMe (NASDAQ:ME) Sets New 1-Year LowHere's Why - MarketBeat
Once worth $6 billion, why is the biology company 23andMe on the brink of bankruptcy? - vietnam.vn
SC US (TTGP), LTD. Acquires New Stake in 23andMe Holding Co - GuruFocus.com
A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds? - The Conversation
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South - ForexTV.com
23andMe Introduces New Feature Helping African Americans - GlobeNewswire
23andMe (NASDAQ:ME) Shares Gap DownTime to Sell? - MarketBeat
23andMe completes reverse stock split By Investing.com - Investing.com Australia
23andMe is on the verge of bankruptcy. It may be too late to delete your genetic data - ABC News
Anne Wojcicki - Forbes
23andMe (NASDAQ:ME) Hits New 1-Year LowTime to Sell? - MarketBeat
What Is Happening With 23andMe Stock Price (ME)? - AskTraders
23andMe Announces Reverse Stock Split and Strategic Adjustments - TipRanks
23andMe Announces Completion of 1-for-20 Reverse Stock Split - The Manila Times
23andMe completes reverse stock split - Investing.com
23andMe announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada
23andMe announces 1-for-20 reverse stock split - Investing.com India
23andMe (NASDAQ:ME) Shares Set to Reverse Split on Wednesday, October 16th - MarketBeat
23andMe Announces 1-for-20 Reverse Stock Split - The Manila Times
23andMe Holding (ME) Announces 1:20 Reverse Share Split - StreetInsider.com
23andMe teams up with Mathew Knowles for genetic testing By Investing.com - Investing.com South Africa
ME23andMe Holding Co. Latest Stock News & Market Updates - StockTitan
23andMe: will customers' DNA go up for sale? - The Week
23andMe teams up with Mathew Knowles for genetic testing - Investing.com India
23andMe Announces Mathew Knowles as New Brand Ambassador - The Manila Times
Millions urged to delete data from mail-order DNA test maker - Yahoo Finance
23andMe’s independent directors quit in clash with CEO over buyout plan - MSN
110,061 Shares in 23andMe Holding Co. (NASDAQ:ME) Purchased by Point72 DIFC Ltd - Defense World
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants - AOL
23andMe CEO Wojcicki now says not interested in outside bids - MSN
Every single member of the board just resigned from DNA tester 23andMe - Yahoo Finance
23andMe's Anne Wojcicki now says her take-private plan is the best option for company - The Business Journals
23 Andme Holding Co Stock (ME) Financials Data
Revenue
Net Income
Cash Flow
EPS
23 Andme Holding Co Stock (ME) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HIBBS KATHY L | Chief Administrative Officer |
May 02 '24 |
Sale |
0.49 |
38,551 |
19,048 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 18 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 18 '24 |
Sale |
0.47 |
38,548 |
18,148 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 04 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 04 '24 |
Sale |
0.50 |
38,548 |
19,282 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 21 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 21 '24 |
Sale |
0.46 |
38,548 |
17,894 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 07 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 07 '24 |
Sale |
0.53 |
38,548 |
20,430 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Feb 22 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,278,375 |
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):